Detalles de la búsqueda
1.
Pharmacodynamics of selective inhibition of γ-secretase by avagacestat.
J Pharmacol Exp Ther;
344(3): 686-95, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23275065
2.
Pharmacokinetic-pharmacodynamic modeling of rifampicin-mediated Cyp3a11 induction in steroid and xenobiotic X receptor humanized mice.
J Pharmacol Exp Ther;
337(1): 75-82, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21205914
3.
In response to "a gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system".
Ann Neurol;
67(1): 143-4; author reply 144-5, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20186950
4.
Pharmacokinetics and pharmacodynamics of gamma-hydroxybutyric acid during tolerance in rats: effects on extracellular dopamine.
J Pharmacol Exp Ther;
320(3): 1252-60, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17138862
5.
Alterations in neuronal transport but not blood-brain barrier transport are observed during gamma-hydroxybutyrate (GHB) sedative/hypnotic tolerance.
Pharm Res;
23(9): 2067-77, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16952000
6.
Neuroinflammatory role of prostaglandins during experimental meningitis: evidence suggestive of an in vivo relationship between nitric oxide and prostaglandins.
J Pharmacol Exp Ther;
304(1): 319-25, 2003 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-12490607
Resultados
1 -
6
de 6
1
Próxima >
>>